ISX and lung carcinoma: To elucidate the transactivation mechanisms of ISX on EMT regulators, co‐immunoprecipitation coupled with two‐dimensional gel electrophoresis (2‐DE) and liquid chromatography–mass spectrometry was conducted to identify ISX‐interacting proteins in lysates of the aggressive lung cancer cell line A549.